Variable | Details | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo | Statistics |
Group | 10 (52.6%) | 9 (47.4%) | 0 | 0 | ||
MDA (nmol/mg prot.) | μ ±SD | 0.525 ±0.187 | 1.31 ±0.401 | T-test: p=0.001 | ||
M (IQR) | 0.47 (0.42-0.64) | 1.14 (1.08-1.57) | ||||
Hepcidin (ng/mg prot.) | μ ±SD | 1.39 ±0.458 | 2.77 ±1.91 | Welch: p=0.140 | ||
M (IQR) | 1.41 (1.08-1.6) | 2.12 (1.58-3.18) | ||||
IL 6 (pg/mg prot.) | μ ±SD | 352.63 ±123.8 | 588.37 ±262.9 | T-test: p=0.075 | ||
M (IQR) | 341.88 (256.81-424.33) | 585.53 (459.6-629.31) | ||||
CRP (pg/mg prot.) | μ ±SD | 0.335 ±0.384 | 0.354 ±0.215 | T-test: p=0.919 | ||
M (IQR) | 0.13 (0.07-0.64) | 0.34 (0.25-0.45) | ||||
Iron (ug/mg prot.) | μ ±SD | 0.564 ±0.108 | 0.766 ±0.176 | T-test: p=0.037 | ||
M (IQR) | 0.56 (0.5-0.62) | 0.75 (0.65-0.86) | ||||
Hepcidin (ng/ml) | μ ±SD | 18.62 ±0.91 | 14.17 ±3.7 | Welch: p=0.092 | ||
M (IQR) | 18.31 (18.16-18.77) | 13.03 (11.96-15.23) | ||||
IL 6 (pg/ml) | μ ±SD | 0.772 ±0.238 | 0.792 ±0.155 | T-test: p=0.861 | ||
M (IQR) | 0.81 (0.7-0.82) | 0.76 (0.7-0.91) | ||||
CRP (pg/ml) | μ ±SD | 0.162 ±0.139 | 0.203 ±0.171 | T-test: p=0.618 | ||
M (IQR) | 0.09 (0.09-0.12) | 0.1 (0.09-0.32) | ||||
Weight (g) | μ ±SD | 334.20 ±34.1 | 272.78 ±34.9 | T-test: p=0.001 | ||
M (IQR) | 334.5 (308.75-357) | 275 (255-285) | ||||
EDV (ml) | μ ±SD | 0.275 ±0.0542 | 0.269 ±0.0739 | T-test: p=0.830 | ||
M (IQR) | 0.29 (0.26-0.31) | 0.26 (0.24-0.29) | ||||
ESV (ml) | μ ±SD | 0.09 ±0.0249 | 0.0826 ±0.0319 | T-test: p=0.578 | ||
M (IQR) | 0.1 (0.08-0.1) | 0.08 (0.06-0.1) | ||||
FE(%) | μ ±SD | 67.78 ±5.34 | 69.79 ±5.32 | T-test: p=0.424 | ||
M (IQR) | 66.4 (64.34-69.36) | 69.63 (65.34-71.86) | ||||
IVSd | μ ±SD | 1.75 ±0.163 | 1.67 ±0.188 | T-test: p=0.320 | ||
M (IQR) | 1.77 (1.67-1.86) | 1.62 (1.53-1.73) | ||||
LVDd | μ ±SD | 5.64 ±0.571 | 5.44 ±0.676 | T-test: p=0.505 | ||
M (IQR) | 5.51 (5.39-6.08) | 5.14 (4.94-5.75) | ||||
LVPWd | μ ±SD | 1.99 ±0.333 | 1.86 ±0.289 | T-test: p=0.378 | ||
M (IQR) | 1.95 (1.87-2.21) | 1.88 (1.68-2.09) | ||||
IVSs | μ ±SD | 2.91 ±0.211 | 2.82 ±0.211 | T-test: p=0.383 | ||
M (IQR) | 2.88 (2.79-3.01) | 2.87 (2.8-2.91) | ||||
LVDs | μ ±SD | 2.85 ±0.461 | 2.72 ±0.516 | T-test: p=0.593 | ||
M (IQR) | 2.74 (2.6-3.05) | 2.73 (2.24-3.03) | ||||
LVPWs | μ ±SD | 2.55 ±0.426 | 2.40 ±0.187 | Welch: p=0.330 | ||
M (IQR) | 2.53 (2.4-2.75) | 2.42 (2.24-2.45) | ||||
FE (%) | μ ±SD | 85.30 ±4.09 | 85.52 ±5.53 | T-test: p=0.923 | ||
M (IQR) | 85.83 (82.75-87.42) | 88 (82.67-89) | ||||
FS(%) | μ ±SD | 49.55 ±4.97 | 49.97 ±6.41 | T-test: p=0.875 | ||
M (IQR) | 49.82 (46.41-51.64) | 52.54 (46-54.04) | ||||
RWT | μ ±SD | 0.671 ±0.0841 | 0.663 ±0.138 | T-test: p=0.885 | ||
M (IQR) | 0.69 (0.62-0.72) | 0.67 (0.55-0.78) | ||||
LVM(g) | μ ±SD | 0.683 ±0.138 | 0.588 ±0.0988 | T-test: p=0.105 | ||
M (IQR) | 0.69 (0.58-0.72) | 0.57 (0.54-0.58) | ||||
Weight (g) | μ ±SD | 324.67 ±29.8 | 284.89 ±36.0 | T-test: p=0.021 | ||
M (IQR) | 310 (304-350) | 290 (262-305) | ||||
EDV (ml) | μ ±SD | 0.191 ±0.0395 | 0.197 ±0.0602 | T-test: p=0.808 | ||
M (IQR) | 0.2 (0.15-0.22) | 0.19 (0.16-0.23) | ||||
ESV (ml) | μ ±SD | 0.043 ±0.0117 | 0.0438 ±0.0165 | T-test: p=0.905 | ||
M (IQR) | 0.05 (0.04-0.05) | 0.04 (0.03-0.05) | ||||
FE(%) | μ ±SD | 77.31 ±4.27 | 76.07 ±6.49 | T-test: p=0.639 | ||
M (IQR) | 75.37 (74.93-77.51) | 78.24 (73.13-81.35) | ||||
IVSd | μ ±SD | 1.79 ±0.255 | 1.56 ±0.224 | T-test: p=0.060 | ||
M (IQR) | 1.76 (1.65-1.92) | 1.57 (1.49-1.64) | ||||
LVDd | μ ±SD | 4.88 ±0.465 | 5.31 ±1.01 | Welch: p=0.269 | ||
M (IQR) | 4.81 (4.49-5.13) | 5.45 (5.2-6.13) | ||||
LVPWd | μ ±SD | 2.35 ±0.19 | 1.71 ±0.288 | T-test: p<0.001 | ||
M (IQR) | 2.32 (2.22-2.45) | 1.74 (1.51-1.98) | ||||
IVSs | μ ±SD | 3.23 ±0.322 | 2.80 ±0.415 | T-test: p=0.025 | ||
M (IQR) | 3.26 (3.05-3.4) | 2.85 (2.51-3.09) | ||||
LVDs | μ ±SD | 1.43 ±0.452 | 1.60 ±0.71 | T-test: p=0.556 | ||
M (IQR) | 1.34 (1.03-1.78) | 1.08 (1.04-2.36) | ||||
LVPWs | μ ±SD | 3.58 ±0.508 | 3.12 ±0.76 | T-test: p=0.154 | ||
M (IQR) | 3.84 (3.44-3.91) | 3.34 (2.7-3.58) | ||||
FE (%) | μ ±SD | 96.44 ±2.88 | 95.70 ±3.85 | T-test: p=0.650 | ||
M (IQR) | 97.33 (95.33-98.67) | 96.33 (92.33-99) | ||||
FS(%) | μ ±SD | 70.73 ±8.45 | 69.82 ±11.3 | T-test: p=0.849 | ||
M (IQR) | 72.15 (65.24-77.1) | 69.41 (59.04-79.99) | ||||
RWT | μ ±SD | 0.858 ±0.118 | 0.635 ±0.126 | T-test: p=0.001 | ||
M (IQR) | 0.82 (0.78-0.91) | 0.62 (0.55-0.69) | ||||
LVM(g) | μ ±SD | 0.652 ±0.102 | 0.527 ±0.191 | T-test: p=0.103 | ||
M (IQR) | 0.66 (0.58-0.69) | 0.55 (0.47-0.58) | ||||
μ ±SD = Mean ± standard deviation; M (IQR) = Median (interquartile interval); |
Variable | Details | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo | Statistics |
Group | 0 | 0 | 10 (50.0%) | 10 (50.0%) | ||
MDA (nmol/mg prot.) | μ ±SD | 0.724 ±0.343 | 1.03 ±0.288 | T-test: p=0.128 | ||
M (IQR) | 0.67 (0.5-0.83) | 0.9 (0.81-1.2) | ||||
Hepcidin (ng/mg prot.) | μ ±SD | 1.87 ±0.673 | 3.24 ±0.929 | T-test: p=0.020 | ||
M (IQR) | 1.8 (1.56-1.91) | 3.3 (2.41-3.95) | ||||
IL 6 (pg/mg prot.) | μ ±SD | 399.09 ±228.8 | 535.32 ±147.0 | T-test: p=0.264 | ||
M (IQR) | 386.64 (243.74-558.77) | 601.42 (410.09-649.59) | ||||
CRP (pg/mg prot.) | μ ±SD | 0.404 ±0.395 | 0.33 ±0.23 | T-test: p=0.714 | ||
M (IQR) | 0.27 (0.16-0.52) | 0.38 (0.14-0.4) | ||||
Iron (ug/mg prot.) | μ ±SD | 0.626 ±0.151 | 0.613 ±0.087 | T-test: p=0.869 | ||
M (IQR) | 0.64 (0.53-0.74) | 0.6 (0.58-0.66) | ||||
Hepcidin (ng/ml) | μ ±SD | 17.37 ±1.65 | 22.37 ±1.38 | T-test: p=0.004 | ||
M (IQR) | 17.21 (16.75-17.84) | 22.09 (21.63-22.84) | ||||
IL 6 (pg/ml) | μ ±SD | 0.90 ±0.518 | 0.658 ±0.174 | Welch: p=0.216 | ||
M (IQR) | 0.68 (0.64-0.77) | 0.62 (0.6-0.64) | ||||
CRP (pg/ml) | μ ±SD | 0.306 ±0.197 | 0.349 ±0.206 | T-test: p=0.662 | ||
M (IQR) | 0.42 (0.1-0.48) | 0.48 (0.11-0.5) | ||||
Weight (g) | μ ±SD | 304.30 ±27.6 | 274.62 ±19.7 | T-test: p=0.021 | ||
M (IQR) | 311.5 (284.5-325.75) | 278.5 (261.5-291) | ||||
EDV (ml) | μ ±SD | 0.264 ±0.0279 | 0.203 ±0.0316 | T-test: p<0.001 | ||
M (IQR) | 0.27 (0.25-0.28) | 0.19 (0.18-0.22) | ||||
ESV (ml) | μ ±SD | 0.0923 ±0.0167 | 0.0517 ±0.0239 | T-test: p<0.001 | ||
M (IQR) | 0.09 (0.08-0.09) | 0.05 (0.03-0.06) | ||||
FE(%) | μ ±SD | 66.70 ±3.34 | 75.15 ±9.49 | Welch: p=0.042 | ||
M (IQR) | 67.63 (66.05-67.99) | 76.31 (68.83-83.29) | ||||
IVSd | μ ±SD | 1.72 ±0.0671 | 1.61 ±0.171 | Welch: p=0.125 | ||
M (IQR) | 1.73 (1.68-1.75) | 1.65 (1.59-1.68) | ||||
LVDd | μ ±SD | 5.63 ±0.434 | 5.53 ±0.672 | T-test: p=0.698 | ||
M (IQR) | 5.67 (5.39-5.88) | 5.49 (5.05-5.84) | ||||
LVPWd | μ ±SD | 1.93 ±0.49 | 1.99 ±0.39 | T-test: p=0.782 | ||
M (IQR) | 1.9 (1.59-2.32) | 1.92 (1.73-2.27) | ||||
IVSs | μ ±SD | 2.91 ±0.302 | 2.91 ±0.425 | T-test: p=0.971 | ||
M (IQR) | 2.79 (2.72-3.05) | 2.82 (2.7-2.91) | ||||
LVDs | μ ±SD | 2.86 ±0.25 | 2.56 ±0.603 | Welch: p=0.216 | ||
M (IQR) | 2.9 (2.67-3.06) | 2.71 (2.22-2.8) | ||||
LVPWs | μ ±SD | 2.51 ±0.219 | 2.70 ±0.271 | T-test: p=0.129 | ||
M (IQR) | 2.55 (2.46-2.66) | 2.78 (2.42-2.89) | ||||
FE (%) | μ ±SD | 84.57 ±4.31 | 89.08 ±3.4 | T-test: p=0.028 | ||
M (IQR) | 83.67 (81.42-87.08) | 88.67 (87-90.5) | ||||
FS(%) | μ ±SD | 49.25 ±7.95 | 55.12 ±6.86 | T-test: p=0.118 | ||
M (IQR) | 47.75 (42.71-51.47) | 52.85 (51.19-56.07) | ||||
RWT | μ ±SD | 0.656 ±0.124 | 0.668 ±0.158 | T-test: p=0.862 | ||
M (IQR) | 0.68 (0.54-0.74) | 0.65 (0.56-0.77) | ||||
LVM(g) | μ ±SD | 0.656 ±0.119 | 0.622 ±0.108 | T-test: p=0.540 | ||
M (IQR) | 0.67 (0.57-0.74) | 0.62 (0.56-0.66) | ||||
Weight (g) | μ ±SD | 312.30 ±27.0 | 276.25 ±18.8 | T-test: p=0.006 | ||
M (IQR) | 315 (292.5-333.25) | 283 (261.75-291.25) | ||||
EDV (ml) | μ ±SD | 0.271 ±0.0797 | 0.223 ±0.0413 | T-test: p=0.137 | ||
M (IQR) | 0.24 (0.23-0.33) | 0.22 (0.19-0.24) | ||||
ESV (ml) | μ ±SD | 0.0737 ±0.0297 | 0.0596 ±0.0258 | T-test: p=0.306 | ||
M (IQR) | 0.06 (0.05-0.09) | 0.06 (0.04-0.08) | ||||
FE(%) | μ ±SD | 73.54 ±4.68 | 73.43 ±8.48 | T-test: p=0.972 | ||
M (IQR) | 71.51 (70.57-78.17) | 73.08 (66.55-79.61) | ||||
IVSd | μ ±SD | 1.71 ±0.255 | 1.67 ±0.198 | T-test: p=0.723 | ||
M (IQR) | 1.65 (1.58-1.92) | 1.71 (1.64-1.78) | ||||
LVDd | μ ±SD | 5.97 ±0.679 | 5.60 ±0.662 | T-test: p=0.262 | ||
M (IQR) | 6.1 (5.72-6.47) | 5.6 (5.14-5.9) | ||||
LVPWd | μ ±SD | 1.81 ±0.343 | 2.02 ±0.387 | T-test: p=0.241 | ||
M (IQR) | 1.81 (1.57-1.92) | 1.95 (1.76-2.32) | ||||
IVSs | μ ±SD | 3.04 ±0.296 | 2.94 ±0.435 | T-test: p=0.551 | ||
M (IQR) | 2.99 (2.86-3.16) | 2.84 (2.72-2.93) | ||||
LVDs | μ ±SD | 2.77 ±0.535 | 2.58 ±0.611 | T-test: p=0.509 | ||
M (IQR) | 2.9 (2.55-3.04) | 2.75 (2.27-2.86) | ||||
LVPWs | μ ±SD | 2.77 ±0.357 | 2.72 ±0.245 | T-test: p=0.769 | ||
M (IQR) | 2.69 (2.52-2.82) | 2.79 (2.52-2.92) | ||||
FE (%) | μ ±SD | 88.37 ±4.26 | 88.75 ±3.93 | T-test: p=0.847 | ||
M (IQR) | 90 (83.92-91.17) | 87.67 (86.67-90) | ||||
FS(%) | μ ±SD | 53.86 ±6.14 | 54.26 ±6.81 | T-test: p=0.896 | ||
M (IQR) | 55.7 (47.63-56.91) | 51.84 (50.4-55.41) | ||||
RWT | μ ±SD | 0.604 ±0.151 | 0.675 ±0.159 | T-test: p=0.352 | ||
M (IQR) | 0.61 (0.5-0.63) | 0.65 (0.57-0.79) | ||||
LVM(g) | μ ±SD | 0.678 ±0.131 | 0.66 ±0.114 | T-test: p=0.771 | ||
M (IQR) | 0.66 (0.6-0.71) | 0.65 (0.6-0.72) | ||||
μ ±SD = Mean ± standard deviation; M (IQR) = Median (interquartile interval); |
Variable | Details | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo | Statistics |
Group | 10 (50.0%) | 0 | 10 (50.0%) | 0 | ||
MDA (nmol/mg prot.) | μ ±SD | 0.525 ±0.187 | 0.724 ±0.343 | T-test: p=0.224 | ||
M (IQR) | 0.47 (0.42-0.64) | 0.67 (0.5-0.83) | ||||
Hepcidin (ng/mg prot.) | μ ±SD | 1.39 ±0.458 | 1.87 ±0.673 | T-test: p=0.175 | ||
M (IQR) | 1.41 (1.08-1.6) | 1.8 (1.56-1.91) | ||||
IL 6 (pg/mg prot.) | μ ±SD | 352.63 ±123.8 | 399.09 ±228.8 | T-test: p=0.662 | ||
M (IQR) | 341.88 (256.81-424.33) | 386.64 (243.74-558.77) | ||||
CRP (pg/mg prot.) | μ ±SD | 0.335 ±0.384 | 0.404 ±0.395 | T-test: p=0.751 | ||
M (IQR) | 0.13 (0.07-0.64) | 0.27 (0.16-0.52) | ||||
Iron (ug/mg prot.) | μ ±SD | 0.564 ±0.108 | 0.626 ±0.151 | T-test: p=0.408 | ||
M (IQR) | 0.56 (0.5-0.62) | 0.64 (0.53-0.74) | ||||
Hepcidin (ng/ml) | μ ±SD | 18.62 ±0.91 | 17.37 ±1.65 | T-test: p=0.235 | ||
M (IQR) | 18.31 (18.16-18.77) | 17.21 (16.75-17.84) | ||||
IL 6 (pg/ml) | μ ±SD | 0.772 ±0.238 | 0.90 ±0.518 | Welch: p=0.513 | ||
M (IQR) | 0.81 (0.7-0.82) | 0.68 (0.64-0.77) | ||||
CRP (pg/ml) | μ ±SD | 0.162 ±0.139 | 0.306 ±0.197 | T-test: p=0.093 | ||
M (IQR) | 0.09 (0.09-0.12) | 0.42 (0.1-0.48) | ||||
Weight (g) | μ ±SD | 334.20 ±34.1 | 304.30 ±27.6 | T-test: p=0.045 | ||
M (IQR) | 334.5 (308.75-357) | 311.5 (284.5-325.75) | ||||
EDV (ml) | μ ±SD | 0.275 ±0.0542 | 0.264 ±0.0279 | T-test: p=0.564 | ||
M (IQR) | 0.29 (0.26-0.31) | 0.27 (0.25-0.28) | ||||
ESV (ml) | μ ±SD | 0.09 ±0.0249 | 0.0923 ±0.0167 | T-test: p=0.809 | ||
M (IQR) | 0.1 (0.08-0.1) | 0.09 (0.08-0.09) | ||||
FE(%) | μ ±SD | 67.78 ±5.34 | 66.70 ±3.34 | T-test: p=0.594 | ||
M (IQR) | 66.4 (64.34-69.36) | 67.63 (66.05-67.99) | ||||
IVSd | μ ±SD | 1.75 ±0.163 | 1.72 ±0.0671 | Welch: p=0.613 | ||
M (IQR) | 1.77 (1.67-1.86) | 1.73 (1.68-1.75) | ||||
LVDd | μ ±SD | 5.64 ±0.571 | 5.63 ±0.434 | T-test: p=0.978 | ||
M (IQR) | 5.51 (5.39-6.08) | 5.67 (5.39-5.88) | ||||
LVPWd | μ ±SD | 1.99 ±0.333 | 1.93 ±0.49 | T-test: p=0.763 | ||
M (IQR) | 1.95 (1.87-2.21) | 1.9 (1.59-2.32) | ||||
IVSs | μ ±SD | 2.91 ±0.211 | 2.91 ±0.302 | T-test: p=0.969 | ||
M (IQR) | 2.88 (2.79-3.01) | 2.79 (2.72-3.05) | ||||
LVDs | μ ±SD | 2.85 ±0.461 | 2.86 ±0.25 | T-test: p=0.921 | ||
M (IQR) | 2.74 (2.6-3.05) | 2.9 (2.67-3.06) | ||||
LVPWs | μ ±SD | 2.55 ±0.426 | 2.51 ±0.219 | T-test: p=0.787 | ||
M (IQR) | 2.53 (2.4-2.75) | 2.55 (2.46-2.66) | ||||
FE (%) | μ ±SD | 85.30 ±4.09 | 84.57 ±4.31 | T-test: p=0.701 | ||
M (IQR) | 85.83 (82.75-87.42) | 83.67 (81.42-87.08) | ||||
FS(%) | μ ±SD | 49.55 ±4.97 | 49.25 ±7.95 | T-test: p=0.920 | ||
M (IQR) | 49.82 (46.41-51.64) | 47.75 (42.71-51.47) | ||||
RWT | μ ±SD | 0.671 ±0.0841 | 0.656 ±0.124 | T-test: p=0.759 | ||
M (IQR) | 0.69 (0.62-0.72) | 0.68 (0.54-0.74) | ||||
LVM(g) | μ ±SD | 0.683 ±0.138 | 0.656 ±0.119 | T-test: p=0.640 | ||
M (IQR) | 0.69 (0.58-0.72) | 0.67 (0.57-0.74) | ||||
Weight (g) | μ ±SD | 324.67 ±29.8 | 312.30 ±27.0 | T-test: p=0.355 | ||
M (IQR) | 310 (304-350) | 315 (292.5-333.25) | ||||
EDV (ml) | μ ±SD | 0.191 ±0.0395 | 0.271 ±0.0797 | T-test: p=0.014 | ||
M (IQR) | 0.2 (0.15-0.22) | 0.24 (0.23-0.33) | ||||
ESV (ml) | μ ±SD | 0.043 ±0.0117 | 0.0737 ±0.0297 | Welch: p=0.011 | ||
M (IQR) | 0.05 (0.04-0.05) | 0.06 (0.05-0.09) | ||||
FE(%) | μ ±SD | 77.31 ±4.27 | 73.54 ±4.68 | T-test: p=0.085 | ||
M (IQR) | 75.37 (74.93-77.51) | 71.51 (70.57-78.17) | ||||
IVSd | μ ±SD | 1.79 ±0.255 | 1.71 ±0.255 | T-test: p=0.497 | ||
M (IQR) | 1.76 (1.65-1.92) | 1.65 (1.58-1.92) | ||||
LVDd | μ ±SD | 4.88 ±0.465 | 5.97 ±0.679 | T-test: p<0.001 | ||
M (IQR) | 4.81 (4.49-5.13) | 6.1 (5.72-6.47) | ||||
LVPWd | μ ±SD | 2.35 ±0.19 | 1.81 ±0.343 | T-test: p<0.001 | ||
M (IQR) | 2.32 (2.22-2.45) | 1.81 (1.57-1.92) | ||||
IVSs | μ ±SD | 3.23 ±0.322 | 3.04 ±0.296 | T-test: p=0.200 | ||
M (IQR) | 3.26 (3.05-3.4) | 2.99 (2.86-3.16) | ||||
LVDs | μ ±SD | 1.43 ±0.452 | 2.77 ±0.535 | T-test: p<0.001 | ||
M (IQR) | 1.34 (1.03-1.78) | 2.9 (2.55-3.04) | ||||
LVPWs | μ ±SD | 3.58 ±0.508 | 2.77 ±0.357 | T-test: p<0.001 | ||
M (IQR) | 3.84 (3.44-3.91) | 2.69 (2.52-2.82) | ||||
FE (%) | μ ±SD | 96.44 ±2.88 | 88.37 ±4.26 | T-test: p<0.001 | ||
M (IQR) | 97.33 (95.33-98.67) | 90 (83.92-91.17) | ||||
FS(%) | μ ±SD | 70.73 ±8.45 | 53.86 ±6.14 | T-test: p<0.001 | ||
M (IQR) | 72.15 (65.24-77.1) | 55.7 (47.63-56.91) | ||||
RWT | μ ±SD | 0.858 ±0.118 | 0.604 ±0.151 | T-test: p<0.001 | ||
M (IQR) | 0.82 (0.78-0.91) | 0.61 (0.5-0.63) | ||||
LVM(g) | μ ±SD | 0.652 ±0.102 | 0.678 ±0.131 | T-test: p=0.645 | ||
M (IQR) | 0.66 (0.58-0.69) | 0.66 (0.6-0.71) | ||||
μ ±SD = Mean ± standard deviation; M (IQR) = Median (interquartile interval); |
Variable | Details | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo | Statistics |
Group | 0 | 9 (47.4%) | 0 | 10 (52.6%) | ||
MDA (nmol/mg prot.) | μ ±SD | 1.31 ±0.401 | 1.03 ±0.288 | T-test: p=0.217 | ||
M (IQR) | 1.14 (1.08-1.57) | 0.9 (0.81-1.2) | ||||
Hepcidin (ng/mg prot.) | μ ±SD | 2.77 ±1.91 | 3.24 ±0.929 | T-test: p=0.626 | ||
M (IQR) | 2.12 (1.58-3.18) | 3.3 (2.41-3.95) | ||||
IL 6 (pg/mg prot.) | μ ±SD | 588.37 ±262.9 | 535.32 ±147.0 | T-test: p=0.699 | ||
M (IQR) | 585.53 (459.6-629.31) | 601.42 (410.09-649.59) | ||||
CRP (pg/mg prot.) | μ ±SD | 0.354 ±0.215 | 0.33 ±0.23 | T-test: p=0.861 | ||
M (IQR) | 0.34 (0.25-0.45) | 0.38 (0.14-0.4) | ||||
Iron (ug/mg prot.) | μ ±SD | 0.766 ±0.176 | 0.613 ±0.087 | T-test: p=0.112 | ||
M (IQR) | 0.75 (0.65-0.86) | 0.6 (0.58-0.66) | ||||
Hepcidin (ng/ml) | μ ±SD | 14.17 ±3.7 | 22.37 ±1.38 | T-test: p=0.006 | ||
M (IQR) | 13.03 (11.96-15.23) | 22.09 (21.63-22.84) | ||||
IL 6 (pg/ml) | μ ±SD | 0.792 ±0.155 | 0.658 ±0.174 | T-test: p=0.164 | ||
M (IQR) | 0.76 (0.7-0.91) | 0.62 (0.6-0.64) | ||||
CRP (pg/ml) | μ ±SD | 0.203 ±0.171 | 0.349 ±0.206 | T-test: p=0.184 | ||
M (IQR) | 0.1 (0.09-0.32) | 0.48 (0.11-0.5) | ||||
Weight (g) | μ ±SD | 272.78 ±34.9 | 274.62 ±19.7 | T-test: p=0.897 | ||
M (IQR) | 275 (255-285) | 278.5 (261.5-291) | ||||
EDV (ml) | μ ±SD | 0.269 ±0.0739 | 0.203 ±0.0316 | Welch: p=0.033 | ||
M (IQR) | 0.26 (0.24-0.29) | 0.19 (0.18-0.22) | ||||
ESV (ml) | μ ±SD | 0.0826 ±0.0319 | 0.0517 ±0.0239 | T-test: p=0.041 | ||
M (IQR) | 0.08 (0.06-0.1) | 0.05 (0.03-0.06) | ||||
FE(%) | μ ±SD | 69.79 ±5.32 | 75.15 ±9.49 | T-test: p=0.166 | ||
M (IQR) | 69.63 (65.34-71.86) | 76.31 (68.83-83.29) | ||||
IVSd | μ ±SD | 1.67 ±0.188 | 1.61 ±0.171 | T-test: p=0.535 | ||
M (IQR) | 1.62 (1.53-1.73) | 1.65 (1.59-1.68) | ||||
LVDd | μ ±SD | 5.44 ±0.676 | 5.53 ±0.672 | T-test: p=0.799 | ||
M (IQR) | 5.14 (4.94-5.75) | 5.49 (5.05-5.84) | ||||
LVPWd | μ ±SD | 1.86 ±0.289 | 1.99 ±0.39 | T-test: p=0.433 | ||
M (IQR) | 1.88 (1.68-2.09) | 1.92 (1.73-2.27) | ||||
IVSs | μ ±SD | 2.82 ±0.211 | 2.91 ±0.425 | T-test: p=0.588 | ||
M (IQR) | 2.87 (2.8-2.91) | 2.82 (2.7-2.91) | ||||
LVDs | μ ±SD | 2.72 ±0.516 | 2.56 ±0.603 | T-test: p=0.555 | ||
M (IQR) | 2.73 (2.24-3.03) | 2.71 (2.22-2.8) | ||||
LVPWs | μ ±SD | 2.40 ±0.187 | 2.70 ±0.271 | T-test: p=0.019 | ||
M (IQR) | 2.42 (2.24-2.45) | 2.78 (2.42-2.89) | ||||
FE (%) | μ ±SD | 85.52 ±5.53 | 89.08 ±3.4 | T-test: p=0.136 | ||
M (IQR) | 88 (82.67-89) | 88.67 (87-90.5) | ||||
FS(%) | μ ±SD | 49.97 ±6.41 | 55.12 ±6.86 | T-test: p=0.130 | ||
M (IQR) | 52.54 (46-54.04) | 52.85 (51.19-56.07) | ||||
RWT | μ ±SD | 0.663 ±0.138 | 0.668 ±0.158 | T-test: p=0.951 | ||
M (IQR) | 0.67 (0.55-0.78) | 0.65 (0.56-0.77) | ||||
LVM(g) | μ ±SD | 0.588 ±0.0988 | 0.622 ±0.108 | T-test: p=0.509 | ||
M (IQR) | 0.57 (0.54-0.58) | 0.62 (0.56-0.66) | ||||
Weight (g) | μ ±SD | 284.89 ±36.0 | 276.25 ±18.8 | T-test: p=0.552 | ||
M (IQR) | 290 (262-305) | 283 (261.75-291.25) | ||||
EDV (ml) | μ ±SD | 0.197 ±0.0602 | 0.223 ±0.0413 | T-test: p=0.325 | ||
M (IQR) | 0.19 (0.16-0.23) | 0.22 (0.19-0.24) | ||||
ESV (ml) | μ ±SD | 0.0438 ±0.0165 | 0.0596 ±0.0258 | T-test: p=0.149 | ||
M (IQR) | 0.04 (0.03-0.05) | 0.06 (0.04-0.08) | ||||
FE(%) | μ ±SD | 76.07 ±6.49 | 73.43 ±8.48 | T-test: p=0.479 | ||
M (IQR) | 78.24 (73.13-81.35) | 73.08 (66.55-79.61) | ||||
IVSd | μ ±SD | 1.56 ±0.224 | 1.67 ±0.198 | T-test: p=0.311 | ||
M (IQR) | 1.57 (1.49-1.64) | 1.71 (1.64-1.78) | ||||
LVDd | μ ±SD | 5.31 ±1.01 | 5.60 ±0.662 | T-test: p=0.495 | ||
M (IQR) | 5.45 (5.2-6.13) | 5.6 (5.14-5.9) | ||||
LVPWd | μ ±SD | 1.71 ±0.288 | 2.02 ±0.387 | T-test: p=0.071 | ||
M (IQR) | 1.74 (1.51-1.98) | 1.95 (1.76-2.32) | ||||
IVSs | μ ±SD | 2.80 ±0.415 | 2.94 ±0.435 | T-test: p=0.507 | ||
M (IQR) | 2.85 (2.51-3.09) | 2.84 (2.72-2.93) | ||||
LVDs | μ ±SD | 1.60 ±0.71 | 2.58 ±0.611 | T-test: p=0.008 | ||
M (IQR) | 1.08 (1.04-2.36) | 2.75 (2.27-2.86) | ||||
LVPWs | μ ±SD | 3.12 ±0.76 | 2.72 ±0.245 | Welch: p=0.168 | ||
M (IQR) | 3.34 (2.7-3.58) | 2.79 (2.52-2.92) | ||||
FE (%) | μ ±SD | 95.70 ±3.85 | 88.75 ±3.93 | T-test: p=0.002 | ||
M (IQR) | 96.33 (92.33-99) | 87.67 (86.67-90) | ||||
FS(%) | μ ±SD | 69.82 ±11.3 | 54.26 ±6.81 | T-test: p=0.004 | ||
M (IQR) | 69.41 (59.04-79.99) | 51.84 (50.4-55.41) | ||||
RWT | μ ±SD | 0.635 ±0.126 | 0.675 ±0.159 | T-test: p=0.577 | ||
M (IQR) | 0.62 (0.55-0.69) | 0.65 (0.57-0.79) | ||||
LVM(g) | μ ±SD | 0.527 ±0.191 | 0.66 ±0.114 | T-test: p=0.107 | ||
M (IQR) | 0.55 (0.47-0.58) | 0.65 (0.6-0.72) | ||||
μ ±SD = Mean ± standard deviation; M (IQR) = Median (interquartile interval); |
Variable | Details | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo | Total | Statistics |
Group | 10 (25.6%) | 9 (23.1%) | 10 (25.6%) | 10 (25.6%) | 39 | ||
MDA (nmol/mg prot.) | μ ±SD | 0.525 ±0.187 | 1.31 ±0.401 | 0.724 ±0.343 | 1.03 ±0.288 | 0.879 ±0.424 | 1-way ANOVA: p=0.002 |
M (min:max) | 0.47 (0.3:0.81) | 1.14 (0.92:1.92) | 0.67 (0.3:1.29) | 0.9 (0.78:1.45) | 0.81 (0.3:1.92) | ||
Hepcidin (ng/mg prot.) | μ ±SD | 1.39 ±0.458 | 2.77 ±1.91 | 1.87 ±0.673 | 3.24 ±0.929 | 2.28 ±1.29 | 1-way ANOVA: p=0.057 |
M (min:max) | 1.41 (0.8:2.07) | 2.12 (1.14:6.3) | 1.8 (1.12:3.11) | 3.3 (2.21:4.34) | 1.89 (0.8:6.3) | ||
IL 6 (pg/mg prot.) | μ ±SD | 352.63 ±123.8 | 588.37 ±262.9 | 399.09 ±228.8 | 535.32 ±147.0 | 460.61 ±214.2 | 1-way ANOVA: p=0.176 |
M (min:max) | 341.88 (214.58:537.19) | 585.53 (256.27:1041.35) | 386.64 (106.09:762.22) | 601.42 (346.73:668.77) | 432.51 (106.09:1041.35) | ||
CRP (pg/mg prot.) | μ ±SD | 0.335 ±0.384 | 0.354 ±0.215 | 0.404 ±0.395 | 0.33 ±0.23 | 0.361 ±0.31 | 1-way ANOVA: p=0.974 |
M (min:max) | 0.13 (0.04:0.84) | 0.34 (0.05:0.68) | 0.27 (0.04:1.25) | 0.38 (0.08:0.66) | 0.33 (0.04:1.25) | ||
Iron (ug/mg prot.) | μ ±SD | 0.564 ±0.108 | 0.766 ±0.176 | 0.626 ±0.151 | 0.613 ±0.087 | 0.642 ±0.15 | 1-way ANOVA: p=0.100 |
M (min:max) | 0.56 (0.42:0.73) | 0.75 (0.55:1.03) | 0.64 (0.42:0.83) | 0.6 (0.49:0.72) | 0.62 (0.42:1.03) | ||
Hepcidin (ng/ml) | μ ±SD | 18.62 ±0.91 | 14.17 ±3.7 | 17.37 ±1.65 | 22.37 ±1.38 | 18.13 ±3.61 | 1-way ANOVA: p=0.002 |
M (min:max) | 18.31 (17.9:19.95) | 13.03 (11.14:19.47) | 17.21 (15.52:19.55) | 22.09 (21.02:24.28) | 18.31 (11.14:24.28) | ||
IL 6 (pg/ml) | μ ±SD | 0.772 ±0.238 | 0.792 ±0.155 | 0.90 ±0.518 | 0.658 ±0.174 | 0.783 ±0.32 | 1-way ANOVA: p=0.506 |
M (min:max) | 0.81 (0.28:1.08) | 0.76 (0.59:0.99) | 0.68 (0.5:2) | 0.62 (0.48:1.07) | 0.7 (0.28:2) | ||
CRP (pg/ml) | μ ±SD | 0.162 ±0.139 | 0.203 ±0.171 | 0.306 ±0.197 | 0.349 ±0.206 | 0.257 ±0.188 | 1-way ANOVA: p=0.147 |
M (min:max) | 0.09 (0.08:0.43) | 0.1 (0.08:0.46) | 0.42 (0.09:0.5) | 0.48 (0.1:0.53) | 0.12 (0.08:0.53) | ||
Weight (g) | μ ±SD | 334.20 ±34.1 | 272.78 ±34.9 | 304.30 ±27.6 | 274.62 ±19.7 | 298.30 ±38.5 | 1-way ANOVA: p<0.001 |
M (min:max) | 334.5 (280:383) | 275 (220:335) | 311.5 (260:338) | 278.5 (245:295) | 295 (220:383) | ||
EDV (ml) | μ ±SD | 0.275 ±0.0542 | 0.269 ±0.0739 | 0.264 ±0.0279 | 0.203 ±0.0316 | 0.255 ±0.0559 | 1-way ANOVA: p=0.021 |
M (min:max) | 0.29 (0.17:0.34) | 0.26 (0.16:0.38) | 0.27 (0.22:0.31) | 0.19 (0.17:0.26) | 0.26 (0.16:0.38) | ||
ESV (ml) | μ ±SD | 0.09 ±0.0249 | 0.0826 ±0.0319 | 0.0923 ±0.0167 | 0.0517 ±0.0239 | 0.0805 ±0.0285 | 1-way ANOVA: p=0.006 |
M (min:max) | 0.1 (0.05:0.12) | 0.08 (0.05:0.14) | 0.09 (0.06:0.13) | 0.05 (0.02:0.09) | 0.09 (0.02:0.14) | ||
FE(%) | μ ±SD | 67.78 ±5.34 | 69.79 ±5.32 | 66.70 ±3.34 | 75.15 ±9.49 | 69.57 ±6.62 | 1-way ANOVA: p=0.033 |
M (min:max) | 66.4 (61.72:77.75) | 69.63 (62.41:80.45) | 67.63 (60.96:72.72) | 76.31 (60.51:86.27) | 67.93 (60.51:86.27) | ||
IVSd | μ ±SD | 1.75 ±0.163 | 1.67 ±0.188 | 1.72 ±0.0671 | 1.61 ±0.171 | 1.69 ±0.155 | 1-way ANOVA: p=0.257 |
M (min:max) | 1.77 (1.43:1.97) | 1.62 (1.49:2.1) | 1.73 (1.6:1.85) | 1.65 (1.27:1.83) | 1.69 (1.27:2.1) | ||
LVDd | μ ±SD | 5.64 ±0.571 | 5.44 ±0.676 | 5.63 ±0.434 | 5.53 ±0.672 | 5.56 ±0.57 | 1-way ANOVA: p=0.873 |
M (min:max) | 5.51 (4.64:6.51) | 5.14 (4.68:6.49) | 5.67 (4.97:6.42) | 5.49 (4.66:6.81) | 5.52 (4.64:6.81) | ||
LVPWd | μ ±SD | 1.99 ±0.333 | 1.86 ±0.289 | 1.93 ±0.49 | 1.99 ±0.39 | 1.94 ±0.373 | 1-way ANOVA: p=0.870 |
M (min:max) | 1.95 (1.26:2.4) | 1.88 (1.33:2.23) | 1.9 (1.08:2.68) | 1.92 (1.46:2.61) | 1.9 (1.08:2.68) | ||
IVSs | μ ±SD | 2.91 ±0.211 | 2.82 ±0.211 | 2.91 ±0.302 | 2.91 ±0.425 | 2.89 ±0.284 | 1-way ANOVA: p=0.900 |
M (min:max) | 2.88 (2.61:3.28) | 2.87 (2.44:3.17) | 2.79 (2.62:3.62) | 2.82 (2.52:3.91) | 2.86 (2.44:3.91) | ||
LVDs | μ ±SD | 2.85 ±0.461 | 2.72 ±0.516 | 2.86 ±0.25 | 2.56 ±0.603 | 2.76 ±0.462 | 1-way ANOVA: p=0.511 |
M (min:max) | 2.74 (2.17:3.74) | 2.73 (1.95:3.5) | 2.9 (2.5:3.18) | 2.71 (1.65:3.58) | 2.75 (1.65:3.74) | ||
LVPWs | μ ±SD | 2.55 ±0.426 | 2.40 ±0.187 | 2.51 ±0.219 | 2.70 ±0.271 | 2.54 ±0.3 | 1-way ANOVA: p=0.249 |
M (min:max) | 2.53 (1.82:3.36) | 2.42 (2.16:2.76) | 2.55 (2.1:2.78) | 2.78 (2.36:3.06) | 2.53 (1.82:3.36) | ||
FE (%) | μ ±SD | 85.30 ±4.09 | 85.52 ±5.53 | 84.57 ±4.31 | 89.08 ±3.4 | 85.97 ±4.55 | 1-way ANOVA: p=0.172 |
M (min:max) | 85.83 (79:91.67) | 88 (74.33:92) | 83.67 (79:92.67) | 88.67 (84.67:94) | 86 (74.33:94) | ||
FS(%) | μ ±SD | 49.55 ±4.97 | 49.97 ±6.41 | 49.25 ±7.95 | 55.12 ±6.86 | 50.78 ±6.76 | 1-way ANOVA: p=0.237 |
M (min:max) | 49.82 (42.44:58.41) | 52.54 (37.94:58.31) | 47.75 (41.69:64.91) | 52.85 (48.78:69.51) | 50.13 (37.94:69.51) | ||
RWT | μ ±SD | 0.671 ±0.0841 | 0.663 ±0.138 | 0.656 ±0.124 | 0.668 ±0.158 | 0.664 ±0.121 | 1-way ANOVA: p=0.994 |
M (min:max) | 0.69 (0.51:0.78) | 0.67 (0.44:0.84) | 0.68 (0.48:0.86) | 0.65 (0.46:0.92) | 0.68 (0.44:0.92) | ||
LVM(g) | μ ±SD | 0.683 ±0.138 | 0.588 ±0.0988 | 0.656 ±0.119 | 0.622 ±0.108 | 0.639 ±0.119 | 1-way ANOVA: p=0.341 |
M (min:max) | 0.69 (0.49:0.95) | 0.57 (0.47:0.76) | 0.67 (0.45:0.84) | 0.62 (0.46:0.82) | 0.61 (0.45:0.95) | ||
Weight (g) | μ ±SD | 324.67 ±29.8 | 284.89 ±36.0 | 312.30 ±27.0 | 276.25 ±18.8 | 300.53 ±33.8 | 1-way ANOVA: p=0.004 |
M (min:max) | 310 (293:378) | 290 (227:346) | 315 (268:354) | 283 (247:295) | 294.5 (227:378) | ||
EDV (ml) | μ ±SD | 0.191 ±0.0395 | 0.197 ±0.0602 | 0.271 ±0.0797 | 0.223 ±0.0413 | 0.222 ±0.0654 | 1-way ANOVA: p=0.020 |
M (min:max) | 0.2 (0.13:0.24) | 0.19 (0.13:0.31) | 0.24 (0.18:0.41) | 0.22 (0.18:0.29) | 0.22 (0.13:0.41) | ||
ESV (ml) | μ ±SD | 0.043 ±0.0117 | 0.0438 ±0.0165 | 0.0737 ±0.0297 | 0.0596 ±0.0258 | 0.0554 ±0.025 | 1-way ANOVA: p=0.015 |
M (min:max) | 0.05 (0.02:0.06) | 0.04 (0.02:0.07) | 0.06 (0.04:0.13) | 0.06 (0.02:0.1) | 0.05 (0.02:0.13) | ||
FE(%) | μ ±SD | 77.31 ±4.27 | 76.07 ±6.49 | 73.54 ±4.68 | 73.43 ±8.48 | 75.09 ±6.05 | 1-way ANOVA: p=0.455 |
M (min:max) | 75.37 (73.76:87.42) | 78.24 (65.35:82.01) | 71.51 (68.33:80.03) | 73.08 (63.56:84.91) | 75.25 (63.56:87.42) | ||
IVSd | μ ±SD | 1.79 ±0.255 | 1.56 ±0.224 | 1.71 ±0.255 | 1.67 ±0.198 | 1.69 ±0.24 | 1-way ANOVA: p=0.241 |
M (min:max) | 1.76 (1.38:2.25) | 1.57 (1.13:1.91) | 1.65 (1.37:2.12) | 1.71 (1.26:1.91) | 1.68 (1.13:2.25) | ||
LVDd | μ ±SD | 4.88 ±0.465 | 5.31 ±1.01 | 5.97 ±0.679 | 5.60 ±0.662 | 5.45 ±0.812 | 1-way ANOVA: p=0.020 |
M (min:max) | 4.81 (4.32:5.75) | 5.45 (3.19:6.39) | 6.1 (4.65:6.73) | 5.6 (4.7:6.83) | 5.49 (3.19:6.83) | ||
LVPWd | μ ±SD | 2.35 ±0.19 | 1.71 ±0.288 | 1.81 ±0.343 | 2.02 ±0.387 | 1.97 ±0.387 | 1-way ANOVA: p<0.001 |
M (min:max) | 2.32 (2.1:2.64) | 1.74 (1.3:2.06) | 1.81 (1.43:2.62) | 1.95 (1.47:2.6) | 1.94 (1.3:2.64) | ||
IVSs | μ ±SD | 3.23 ±0.322 | 2.80 ±0.415 | 3.04 ±0.296 | 2.94 ±0.435 | 3.00 ±0.386 | 1-way ANOVA: p=0.104 |
M (min:max) | 3.26 (2.68:3.8) | 2.85 (2.1:3.4) | 2.99 (2.63:3.6) | 2.84 (2.54:3.96) | 2.96 (2.1:3.96) | ||
LVDs | μ ±SD | 1.43 ±0.452 | 1.60 ±0.71 | 2.77 ±0.535 | 2.58 ±0.611 | 2.10 ±0.818 | 1-way ANOVA: p<0.001 |
M (min:max) | 1.34 (0.95:2.09) | 1.08 (0.95:2.6) | 2.9 (1.68:3.44) | 2.75 (1.62:3.56) | 2.15 (0.95:3.56) | ||
LVPWs | μ ±SD | 3.58 ±0.508 | 3.12 ±0.76 | 2.77 ±0.357 | 2.72 ±0.245 | 3.05 ±0.597 | 1-way ANOVA: p=0.004 |
M (min:max) | 3.84 (2.4:3.99) | 3.34 (1.67:3.96) | 2.69 (2.45:3.62) | 2.79 (2.4:3) | 2.93 (1.67:3.99) | ||
FE (%) | μ ±SD | 96.44 ±2.88 | 95.70 ±3.85 | 88.37 ±4.26 | 88.75 ±3.93 | 92.31 ±5.27 | 1-way ANOVA: p<0.001 |
M (min:max) | 97.33 (90.33:99) | 96.33 (88.67:99) | 90 (83:94.33) | 87.67 (84:96) | 92.5 (83:99) | ||
FS(%) | μ ±SD | 70.73 ±8.45 | 69.82 ±11.3 | 53.86 ±6.14 | 54.26 ±6.81 | 62.15 ±11.5 | 1-way ANOVA: p<0.001 |
M (min:max) | 72.15 (55.64:81.91) | 69.41 (53.14:83.46) | 55.7 (46.24:63.71) | 51.84 (47.91:68.54) | 59.49 (46.24:83.46) | ||
RWT | μ ±SD | 0.858 ±0.118 | 0.635 ±0.126 | 0.604 ±0.151 | 0.675 ±0.159 | 0.691 ±0.167 | 1-way ANOVA: p=0.002 |
M (min:max) | 0.82 (0.72:1.09) | 0.62 (0.48:0.9) | 0.61 (0.42:0.92) | 0.65 (0.45:0.92) | 0.68 (0.42:1.09) | ||
LVM(g) | μ ±SD | 0.652 ±0.102 | 0.527 ±0.191 | 0.678 ±0.131 | 0.66 ±0.114 | 0.63 ±0.147 | 1-way ANOVA: p=0.104 |
M (min:max) | 0.66 (0.48:0.82) | 0.55 (0.2:0.79) | 0.66 (0.47:0.9) | 0.65 (0.48:0.85) | 0.63 (0.2:0.9) | ||
μ ±SD = Mean ± standard deviation; M (min:max) = Median (min:max); |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.002 | p=0.326 | p=0.065 | |
Placebo - ISO | p=0.002 | p=0.013 | p=0.326 | |
ISO - DFP | p=0.326 | p=0.013 | p=0.326 | |
ISO - Placebo | p=0.065 | p=0.326 | p=0.326 | |
Overall Anova test: p=0.002 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.256 | p=0.945 | p=0.091 | |
Placebo - ISO | p=0.256 | p=0.579 | p=0.945 | |
ISO - DFP | p=0.945 | p=0.579 | p=0.256 | |
ISO - Placebo | p=0.091 | p=0.945 | p=0.256 | |
Overall Anova test: p=0.057 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.351 | p>0.999 | p=0.617 | |
Placebo - ISO | p=0.351 | p=0.503 | p>0.999 | |
ISO - DFP | p>0.999 | p=0.503 | p=0.765 | |
ISO - Placebo | p=0.617 | p>0.999 | p=0.765 | |
Overall Anova test: p=0.176 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.974 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.115 | p>0.999 | p>0.999 | |
Placebo - ISO | p=0.115 | p=0.371 | p=0.371 | |
ISO - DFP | p>0.999 | p=0.371 | p>0.999 | |
ISO - Placebo | p>0.999 | p=0.371 | p>0.999 | |
Overall Anova test: p=0.100 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.056 | p=0.437 | p=0.096 | |
Placebo - ISO | p=0.056 | p=0.121 | p=0.001 | |
ISO - DFP | p=0.437 | p=0.121 | p=0.036 | |
ISO - Placebo | p=0.096 | p=0.001 | p=0.036 | |
Overall Anova test: p=0.002 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.809 | |
ISO - Placebo | p>0.999 | p>0.999 | p=0.809 | |
Overall Anova test: p=0.506 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p=0.510 | p=0.248 | |
Placebo - ISO | p>0.999 | p=0.865 | p=0.575 | |
ISO - DFP | p=0.510 | p=0.865 | p>0.999 | |
ISO - Placebo | p=0.248 | p=0.575 | p>0.999 | |
Overall Anova test: p=0.147 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p<0.001 | p=0.116 | p=0.001 | |
Placebo - ISO | p<0.001 | p=0.116 | p=0.900 | |
ISO - DFP | p=0.116 | p=0.116 | p=0.116 | |
ISO - Placebo | p=0.001 | p=0.900 | p=0.116 | |
Overall Anova test: p<0.001 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p=0.029 | |
Placebo - ISO | p>0.999 | p>0.999 | p=0.056 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.062 | |
ISO - Placebo | p=0.029 | p=0.056 | p=0.062 | |
Overall Anova test: p=0.021 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p=0.013 | |
Placebo - ISO | p>0.999 | p>0.999 | p=0.060 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.009 | |
ISO - Placebo | p=0.013 | p=0.060 | p=0.009 | |
Overall Anova test: p=0.006 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.953 | p=0.953 | p=0.076 | |
Placebo - ISO | p=0.953 | p=0.828 | p=0.314 | |
ISO - DFP | p=0.953 | p=0.828 | p=0.036 | |
ISO - Placebo | p=0.076 | p=0.314 | p=0.036 | |
Overall Anova test: p=0.033 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.991 | p>0.999 | p=0.391 | |
Placebo - ISO | p=0.991 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.708 | |
ISO - Placebo | p=0.391 | p>0.999 | p=0.708 | |
Overall Anova test: p=0.257 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.873 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.870 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.900 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.511 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p=0.289 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.976 | |
ISO - Placebo | p>0.999 | p=0.289 | p=0.976 | |
Overall Anova test: p=0.249 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p=0.399 | |
Placebo - ISO | p>0.999 | p>0.999 | p=0.424 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.230 | |
ISO - Placebo | p=0.399 | p=0.424 | p=0.230 | |
Overall Anova test: p=0.172 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p=0.428 | |
Placebo - ISO | p>0.999 | p>0.999 | p=0.476 | |
ISO - DFP | p>0.999 | p>0.999 | p=0.424 | |
ISO - Placebo | p=0.428 | p=0.476 | p=0.424 | |
Overall Anova test: p=0.237 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.994 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.526 | p>0.999 | p>0.999 | |
Placebo - ISO | p=0.526 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.341 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.031 | p=0.713 | p=0.009 | |
Placebo - ISO | p=0.031 | p=0.138 | p=0.713 | |
ISO - DFP | p=0.713 | p=0.138 | p=0.050 | |
ISO - Placebo | p=0.009 | p=0.713 | p=0.050 | |
Overall Anova test: p=0.004 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.832 | p=0.032 | p=0.824 | |
Placebo - ISO | p=0.832 | p=0.047 | p=0.824 | |
ISO - DFP | p=0.032 | p=0.047 | p=0.358 | |
ISO - Placebo | p=0.824 | p=0.824 | p=0.358 | |
Overall Anova test: p=0.020 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.939 | p=0.031 | p=0.538 | |
Placebo - ISO | p=0.939 | p=0.032 | p=0.538 | |
ISO - DFP | p=0.031 | p=0.032 | p=0.538 | |
ISO - Placebo | p=0.538 | p=0.538 | p=0.538 | |
Overall Anova test: p=0.015 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p>0.999 | p>0.999 | |
Placebo - ISO | p>0.999 | p>0.999 | p>0.999 | |
ISO - DFP | p>0.999 | p>0.999 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.455 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.285 | p>0.999 | p>0.999 | |
Placebo - ISO | p=0.285 | p=0.911 | p>0.999 | |
ISO - DFP | p>0.999 | p=0.911 | p>0.999 | |
ISO - Placebo | p>0.999 | p>0.999 | p>0.999 | |
Overall Anova test: p=0.241 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.662 | p=0.016 | p=0.249 | |
Placebo - ISO | p=0.662 | p=0.249 | p=0.662 | |
ISO - DFP | p=0.016 | p=0.249 | p=0.662 | |
ISO - Placebo | p=0.249 | p=0.662 | p=0.662 | |
Overall Anova test: p=0.020 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p<0.001 | p=0.004 | p=0.157 | |
Placebo - ISO | p<0.001 | p=0.448 | p=0.157 | |
ISO - DFP | p=0.004 | p=0.448 | p=0.324 | |
ISO - Placebo | p=0.157 | p=0.157 | p=0.324 | |
Overall Anova test: p<0.001 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.104 | p=0.814 | p=0.547 | |
Placebo - ISO | p=0.104 | p=0.623 | p=0.875 | |
ISO - DFP | p=0.814 | p=0.623 | p=0.875 | |
ISO - Placebo | p=0.547 | p=0.875 | p=0.875 | |
Overall Anova test: p=0.104 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p<0.001 | p=0.001 | |
Placebo - ISO | p>0.999 | p<0.001 | p=0.005 | |
ISO - DFP | p<0.001 | p<0.001 | p>0.999 | |
ISO - Placebo | p=0.001 | p=0.005 | p>0.999 | |
Overall Anova test: p<0.001 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.262 | p=0.009 | p=0.009 | |
Placebo - ISO | p=0.262 | p=0.349 | p=0.349 | |
ISO - DFP | p=0.009 | p=0.349 | p=0.855 | |
ISO - Placebo | p=0.009 | p=0.349 | p=0.855 | |
Overall Anova test: p=0.004 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p<0.001 | p<0.001 | |
Placebo - ISO | p>0.999 | p<0.001 | p=0.002 | |
ISO - DFP | p<0.001 | p<0.001 | p>0.999 | |
ISO - Placebo | p<0.001 | p=0.002 | p>0.999 | |
Overall Anova test: p<0.001 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p>0.999 | p<0.001 | p=0.001 | |
Placebo - ISO | p>0.999 | p=0.001 | p=0.002 | |
ISO - DFP | p<0.001 | p=0.001 | p>0.999 | |
ISO - Placebo | p=0.001 | p=0.002 | p>0.999 | |
Overall Anova test: p<0.001 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.009 | p=0.002 | p=0.044 | |
Placebo - ISO | p=0.009 | p>0.999 | p>0.999 | |
ISO - DFP | p=0.002 | p>0.999 | p=0.885 | |
ISO - Placebo | p=0.044 | p>0.999 | p=0.885 | |
Overall Anova test: p=0.002 |
Pairwise | DFP - ISO | Placebo - ISO | ISO - DFP | ISO - Placebo |
DFP - ISO | p=0.290 | p>0.999 | p>0.999 | |
Placebo - ISO | p=0.290 | p=0.150 | p=0.290 | |
ISO - DFP | p>0.999 | p=0.150 | p>0.999 | |
ISO - Placebo | p>0.999 | p=0.290 | p>0.999 | |
Overall Anova test: p=0.104 |
.